Skip to content

Clinical trials

Lysosomal Storage Diseases trials in Brazil

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lysosomal Storage Diseases Country / region: Brazil Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20071
20082
20112
20141
20152
20182
20191
20201
20211
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Terminated4
Active, not recruiting2
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Shire4
BioMarin Pharmaceutical3
AVROBIO2
Gemma Biotherapeutics2
Alexion Pharmaceuticals, Inc.1
Azafaros B.V.1
REGENXBIO Inc.1
Ultragenyx Pharmaceutical Inc1
University of Pennsylvania1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lysosomal Storage Diseases16
Mucopolysaccharidosis II4
Sudden Infant Death4
Gangliosidosis, GM13
Genetic Diseases, Inborn3
Metabolic Diseases3
Mucopolysaccharidosis IV3
Rare Diseases3
Fabry Disease2
Lipid Metabolism Disorders2

Trials

Showing 51 to 16 of 16. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.